Bioorthogonal Engineering of Tumors with Bacterial Antigens Leverages Innate Immunity for Enhanced Adoptive T Cell Therapy
Substantial efforts in adoptive T-cell therapy have centered on boosting T-cell activity against tumors. However, a crucial yet overlooked factor is that the onset and maintenance of T-cell responses are highly dependent on innate immunity. Here, we developed a strategy of engineering tumors with bacterial antigens via click chemistry to cross-regulate innate-adaptive immunity, thereby enhancing the efficacy of adoptive T-cell therapy in solid tumors. The targeted delivery of bacterial antigens is mediated by azido sugar liposomes (TALP) for introducing azide groups on tumors and dibenzocyclooctyne-decorated bacterial membranes (DBCO-BM) to endow tumor cells with the innate immunogenicity of bacteria. Our study reveals that tumors with exposed bacterial antigens trigger innate immune responses for direct tumor killing and drive T-cell tumor infiltration to launch adaptive immunity. The antitumor functions of adoptive T cells are significantly augmented with the cross-activation of innate-adaptive immunity. This study highlights the potential of innate immunity in addressing the suboptimal response of adoptive T cells in solid tumors.
Authors
- Wen Li (ORCID: https://orcid.org/0000-0001-6783-1464)
- Xian‐Zheng Zhang (ORCID: https://orcid.org/0000-0001-6242-6005)
- Ruilin Li (ORCID: https://orcid.org/0000-0001-7739-1765)
- Ping Ji (ORCID: https://orcid.org/0000-0002-3027-6142)
- Xuan Zeng (ORCID: https://orcid.org/0009-0002-3063-5800)
- Wei-Qin Yao (ORCID: https://orcid.org/0000-0002-2039-2852)
- Jun Feng
- Wen-Fang Song (ORCID: https://orcid.org/0000-0001-6025-0165)
Institutions
- Wuhan University (CN)
Publication Details
- Journal
- ACS Nano
- Published
- 2026-11-20
- DOI
- https://doi.org/10.1021/acsnano.6c18896
- Primary Topic
- Immunotherapy and Immune Responses
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China